What do we really know about the ubiquitin-proteasome pathway in muscle atrophy?

Studies of many different rodent models of muscle wasting have indicated that accelerated proteolysis via the ubiquitin-proteasome pathway is the principal cause of muscle atrophy induced by fasting, cancer cachexia, metabolic acidosis, denervation, disuse, diabetes, sepsis, burns, hyperthyroidism and excess glucocorticoids. However, our understanding about how muscle proteins are degraded, and how the ubiquitin-proteasome pathway is activated in muscle under these conditions, is still very limited. The identities of the important ubiquitin-protein ligases in skeletal muscle, and the ways in which they recognize substrates are still largely unknown. Recent in-vitro studies have suggested that one set of ubquitination enzymes, E214K and E3α, which are responsible for the ‘N-end rule’ system of ubiquitination, plays an important role in muscle, especially in catabolic states. However, their functional significance in degrading different muscle proteins is still unclear. This review focuses on the many gaps in our understanding of the functioning of the ubiquitin-proteasome pathway in muscle atrophy, and highlights the strengths and limitations of the different experimental approaches used in such studies.

[1]  T. Meyer,et al.  Sepsis is associated with increased mRNAs of the ubiquitin-proteasome proteolytic pathway in human skeletal muscle. , 1997, The Journal of clinical investigation.

[2]  J. Ruderman,et al.  Cell cycle-regulated proteolysis of mitotic target proteins. , 1999, Molecular biology of the cell.

[3]  S. Arfin,et al.  A Mouse Amidase Specific for N-terminal Asparagine , 1996, The Journal of Biological Chemistry.

[4]  D. Garrel,et al.  Activation of the ubiquitin pathway in rat skeletal muscle by catabolic doses of glucocorticoids. , 1997, The American journal of physiology.

[5]  A. Goldberg,et al.  Inhibitors of the proteasome reduce the accelerated proteolysis in atrophying rat skeletal muscles. , 1997, The Journal of clinical investigation.

[6]  A. Goldberg,et al.  Increase in ubiquitin-protein conjugates concomitant with the increase in proteolysis in rat skeletal muscle during starvation and atrophy denervation. , 1995, The Biochemical journal.

[7]  D. Breuillé,et al.  Muscle wasting in a rat model of long-lasting sepsis results from the activation of lysosomal, Ca2+ -activated, and ubiquitin-proteasome proteolytic pathways. , 1996, The Journal of clinical investigation.

[8]  A. Goldberg,et al.  Role of different proteolytic systems in the degradation of muscle proteins during denervation atrophy. , 1990, The Journal of biological chemistry.

[9]  T. Pritts,et al.  The gene expression of ubiquitin ligase E3alpha is upregulated in skeletal muscle during sepsis in rats-potential role of glucocorticoids. , 2000, Biochemical and biophysical research communications.

[10]  A. Ciechanover,et al.  Purification and characterization of arginyl-tRNA-protein transferase from rabbit reticulocytes. Its involvement in post-translational modification and degradation of acidic NH2 termini substrates of the ubiquitin pathway. , 1988, The Journal of biological chemistry.

[11]  A. Varshavsky,et al.  The N-end rule: functions, mysteries, uses. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[12]  C. Guézennec,et al.  Coordinate activation of lysosomal, Ca 2+-activated and ATP-ubiquitin-dependent proteinases in the unweighted rat soleus muscle. , 1996, The Biochemical journal.

[13]  M. Solomon,et al.  A Predictive Scale for Evaluating Cyclin-dependent Kinase Substrates , 1996, The Journal of Biological Chemistry.

[14]  A. Goldberg,et al.  A soluble ATP-dependent proteolytic system responsible for the degradation of abnormal proteins in reticulocytes. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[15]  J. Estrela,et al.  Increased ATP-ubiquitin-dependent proteolysis in skeletal muscles of tumor-bearing rats. , 1994, Cancer research.

[16]  A. Goldberg,et al.  Activation of the ubiquitin-ATP-dependent proteolytic system in skeletal muscle during fasting and denervation atrophy. , 1991, Biomedica biochimica acta.

[17]  A. Goldberg,et al.  Proteasome inhibitors: valuable new tools for cell biologists. , 1998, Trends in cell biology.

[18]  J. Wang,et al.  Energy-ubiquitin-dependent muscle proteolysis during sepsis in rats is regulated by glucocorticoids. , 1996, The Journal of clinical investigation.

[19]  A. Goldberg,et al.  The activation of protein degradation in muscle by Ca2+ or muscle injury does not involve a lysosomal mechanism. , 1986, The Biochemical journal.

[20]  J. Fischer,et al.  The expression of genes in the ubiquitin-proteasome proteolytic pathway is increased in skeletal muscle from patients with cancer. , 1999, Surgery.

[21]  A. Varshavsky,et al.  In vivo half-life of a protein is a function of its amino-terminal residue. , 1986, Science.

[22]  S. Wing,et al.  14-kDa ubiquitin-conjugating enzyme: structure of the rat gene and regulation upon fasting and by insulin. , 1994, The American journal of physiology.

[23]  T. Maniatis,et al.  Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway. , 1995, Genes & development.

[24]  N. Agell,et al.  Ubiquitin gene expression is increased in skeletal muscle of tumour‐bearing rats , 1994, FEBS letters.

[25]  A. Goldberg,et al.  The N-end Rule Pathway Catalyzes a Major Fraction of the Protein Degradation in Skeletal Muscle* , 1998, The Journal of Biological Chemistry.

[26]  B. Lowell,et al.  Evidence that lysosomes are not involved in the degradation of myofibrillar proteins in rat skeletal muscle. , 1986, The Biochemical journal.

[27]  W. Mitch,et al.  The acidosis of chronic renal failure activates muscle proteolysis in rats by augmenting transcription of genes encoding proteins of the ATP-dependent ubiquitin-proteasome pathway. , 1996, The Journal of clinical investigation.

[28]  A Ciechanover,et al.  The ubiquitin-proteasome pathway and pathogenesis of human diseases. , 1999, Annual review of medicine.

[29]  A. Goldberg,et al.  Rates of ubiquitin conjugation increase when muscles atrophy, largely through activation of the N-end rule pathway. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[30]  A. Goldberg,et al.  Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules , 1994, Cell.

[31]  A. Goldberg,et al.  Increase in levels of polyubiquitin and proteasome mRNA in skeletal muscle during starvation and denervation atrophy. , 1995, The Biochemical journal.

[32]  J. Hoeijmakers,et al.  Inactivation of the HR6B Ubiquitin-Conjugating DNA Repair Enzyme in Mice Causes Male Sterility Associated with Chromatin Modification , 1996, Cell.

[33]  A. Hershko,et al.  Specificity of binding of NH2-terminal residue of proteins to ubiquitin-protein ligase. Use of amino acid derivatives to characterize specific binding sites. , 1988, The Journal of biological chemistry.

[34]  A. Goldberg,et al.  Glucocorticoids activate the ATP-ubiquitin-dependent proteolytic system in skeletal muscle during fasting. , 1993, The American journal of physiology.

[35]  A. Ciechanover,et al.  Isolation, Characterization, and Partial Purification of a Novel Ubiquitin-Protein Ligase, E3 , 1996, The Journal of Biological Chemistry.

[36]  A. Goldberg,et al.  Metabolic acidosis stimulates muscle protein degradation by activating the adenosine triphosphate-dependent pathway involving ubiquitin and proteasomes. , 1994, The Journal of clinical investigation.

[37]  D. Bredesen,et al.  Cleavage of actin by interleukin 1 beta-converting enzyme to reverse DNase I inhibition. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[38]  B. Beaufrère,et al.  Increased mRNA levels for components of the lysosomal, Ca2+-activated, and ATP-ubiquitin-dependent proteolytic pathways in skeletal muscle from head trauma patients. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[39]  L. Phillips,et al.  Muscle wasting in insulinopenic rats results from activation of the ATP-dependent, ubiquitin-proteasome proteolytic pathway by a mechanism including gene transcription. , 1996, The Journal of clinical investigation.

[40]  J. Fischer,et al.  Activity and expression of the 20S proteasome are increased in skeletal muscle during sepsis. , 1999, American journal of physiology. Regulatory, integrative and comparative physiology.

[41]  A. Ciechanover,et al.  The ubiquitin system for protein degradation. , 1992, Annual review of biochemistry.

[42]  A. Goldberg,et al.  Muscle protein breakdown and the critical role of the ubiquitin-proteasome pathway in normal and disease states. , 1999, The Journal of nutrition.

[43]  A. Goldberg,et al.  Activation of the ATP-ubiquitin-proteasome pathway in skeletal muscle of cachectic rats bearing a hepatoma. , 1995, The American journal of physiology.

[44]  J. Fischer,et al.  Sepsis stimulates release of myofilaments in skeletal muscle by a calcium‐dependent mechanism , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[45]  Wei Xu,et al.  Editing of ubiquitin conjugates by an isopeptidase in the 26S proteasome , 1997, Nature.

[46]  A. Varshavsky,et al.  Inhibition of the N-end rule pathway in living cells. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[47]  A. Goldberg,et al.  Importance of the ATP-Ubiquitin-Proteasome Pathway in the Degradation of Soluble and Myofibrillar Proteins in Rabbit Muscle Extracts* , 1996, The Journal of Biological Chemistry.

[48]  A. Varshavsky,et al.  Peptides accelerate their uptake by activating a ubiquitin-dependent proteolytic pathway , 2000, Nature.

[49]  R. Deshaies.  SCF and Cullin/Ring H2-based ubiquitin ligases. , 1999, Annual review of cell and developmental biology.

[50]  N. Copeland,et al.  The mouse and human genes encoding the recognition component of the N-end rule pathway. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[51]  N. Agell,et al.  Muscle wasting associated with cancer cachexia is linked to an important activation of the atp‐dependent ubiquitin‐mediated proteolysis , 1995, International journal of cancer.

[52]  Wolfgang Baumeister,et al.  The Proteasome: Paradigm of a Self-Compartmentalizing Protease , 1998, Cell.

[53]  A. Goldberg,et al.  Ubiquitin conjugation by the N-end rule pathway and mRNAs for its components increase in muscles of diabetic rats. , 1999, The Journal of clinical investigation.

[54]  J. Fischer,et al.  Sepsis is associated with increased ubiquitinconjugating enzyme E214k mRNA in skeletal muscle. , 1999, American journal of physiology. Regulatory, integrative and comparative physiology.

[55]  Claudine Jurkovitz,et al.  Evaluation of signals activating ubiquitin-proteasome proteolysis in a model of muscle wasting. , 1999, American journal of physiology. Cell physiology.

[56]  S. Madihally,et al.  Insulin suppresses the increased activities of lysosomal cathepsins and ubiquitin conjugation system in burn-injured rats. , 2000, The Journal of surgical research.

[57]  A. Varshavsky,et al.  The recognition component of the N‐end rule pathway. , 1990, The EMBO journal.

[58]  D. Chrysis,et al.  Regulation of components of the ubiquitin system by insulin-like growth factor I and growth hormone in skeletal muscle of rats made catabolic with dexamethasone. , 1999, Endocrinology.

[59]  C. Pickart,et al.  Ubiquitin in chains. , 2000, Trends in biochemical sciences.